Flexion synergy overshadows flexor spasticity during reaching in chronic moderate to severe hemiparetic stroke.

Journal: Clinical neurophysiology : official journal of the International Federation of Clinical Neurophysiology

Published Date: Jul 1, 2017

Abstract

OBJECTIVE: Pharmaceutical intervention targets arm flexor spasticity with an often-unsuccessful goal of improving function. Flexion synergy is a related motor impairment that may be inadvertently neglected. Here, flexor spasticity and flexion synergy are disentangled to determine their contributions to reaching dysfunction.

Authors

Michael D Ellis

Department of Physical Therapy and Human Movement Sciences, Feinberg School of Medicine, Northwestern University, 645 N. Michigan Ave. Suite 1100, Chicago, IL, 60611, USA. m-ellis@northwestern.edu.
Ingrid Schut

Faculty of Science and Technology, University of Twente, Enschede, Netherlands.
Julius P A Dewald

Department of Physical Therapy and Human Movement Sciences, Feinberg School of Medicine, Northwestern University, 645 N. Michigan Ave. Suite 1100, Chicago, IL, 60611, USA.

Keywords

Aged Arm Chronic Disease Cross-Sectional Studies Electromyography Female Humans Male Middle Aged Movement Muscle Spasticity Paresis Prospective Studies Range of Motion, Articular Robotics Severity of Illness Index Stroke

External Resources

View on PubMed Access via DOI PubMed (28558314)

Flexion synergy overshadows flexor spasticity during reaching in chronic moderate to severe hemiparetic stroke.

Abstract

Authors

Keywords

External Resources

Popular Topics

Recent Journals